Skip to main content
SpringerLink
Log in

Early Intervention in Psychosis

  • Chapter
  • First Online:
Schizophrenia Treatment Outcomes

  • 2187 Accesses

Abstract

In the past 20 years, the evidence confirming the superiority of specialised early intervention services over generic care in managing the critical early phase of psychosis has grown steadily, and specialised early intervention services have been established in many parts of the developed world. The multidisciplinary, comprehensive and assertive approach of early intervention services was based on ground-breaking research showing the importance of minimising the duration of untreated psychosis, defining “at-risk” populations and optimising delivery of evidence-based treatment (psychotropic medication, other medication and non-pharmacological). Whilst studies have repeatedly shown positive short- and medium-term outcomes for early-intervention services, these appear to dissipate once care reverts to generic services. Early intervention in psychosis is now considered one of the most important mental health reforms since the era of deinstitutionalisation. Research efforts are now concentrating on understanding the pathophysiological processes that accompany the emergence and progression of psychosis, improving identification and treatment of at-risk mental states, developing focused early detection strategies and extending the early intervention paradigm to all youth mental health disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.

    Article  PubMed  Google Scholar 

  2. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–22.

    Article  PubMed  Google Scholar 

  3. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry. 2008;7(3):148–56.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Collaborators GBoDS. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800.

    Article  Google Scholar 

  5. Organization WH. Management of Schizophrenia 2013. [Online] www.who.int/mental_health/management/schizophrenia/en

  6. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296–306.

    Article  PubMed  Google Scholar 

  7. Valmaggia LR, Byrne M, Day F, Broome MR, Johns L, Howes O, et al. Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase. Br J Psychiatry. 2015;207(2):130–4.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, et al. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016;15(7):485–515.

    Article  PubMed  Google Scholar 

  9. Chong HY, Teoh SL, Wu DB, Kotirum S, Chiou CF, Chaiyakunapruk N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016;12:357–73.

    PubMed  PubMed Central  Google Scholar 

  10. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiat. 2015;72(4):334–41.

    Article  Google Scholar 

  11. McGorry PD. The specialist youth mental health model: strengthening the weakest link in the public mental health system. Med J Aust. 2007;187(7 Suppl):S53–6.

    PubMed  Google Scholar 

  12. Craig TK, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, et al. The Lambeth early onset (LEO) team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ. 2004;329(7474):1067.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlaeger J, le Quach P, et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry. 2008;65(7):762–71.

    Article  PubMed  Google Scholar 

  14. Singh SP. Early intervention in psychosis. Br J Psychiatry. 2010;196(5):343–5.

    Article  PubMed  Google Scholar 

  15. Johannessen JO, Larsen TK, Joa I, Melle I, Friis S, Opjordsmoen S, et al. Pathways to care for first-episode psychosis in an early detection healthcare sector: part of the Scandinavian TIPS study. Br J Psychiatry Suppl. 2005;48:s24–8.

    Article  PubMed  Google Scholar 

  16. Rosenbaum B, Valbak K, Harder S, Knudsen P, Koster A, Lajer M, et al. The Danish National Schizophrenia Project: prospective, comparative longitudinal treatment study of first-episode psychosis. Br J Psychiatry. 2005;186:394–9.

    Article  PubMed  Google Scholar 

  17. Cullberg J, Levander S, Holmqvist R, Mattsson M, Wieselgren IM. One-year outcome in first episode psychosis patients in the Swedish parachute project. Acta Psychiatr Scand. 2002;106(4):276–85.

    Article  PubMed  Google Scholar 

  18. Grawe RW, Falloon IR, Widen JH, Skogvoll E. Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatr Scand. 2006;114(5):328–36.

    Article  PubMed  Google Scholar 

  19. Kuipers E, Holloway F, Rabe-Hesketh S, Tennakoon L, Croydon O, Assertive Support T. An RCT of early intervention in psychosis: Croydon outreach and Assertive Support team (COAST). Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):358–63.

    Article  PubMed  Google Scholar 

  20. Chen EY, Tang JY, Hui CL, Chiu CP, Lam MM, Law CW, et al. Three-year outcome of phase-specific early intervention for first-episode psychosis: a cohort study in Hong Kong. Early Interv Psychiatry. 2011;5(4):315–23.

    Article  PubMed  Google Scholar 

  21. McGorry P, Johanessen JO, Lewis S, Birchwood M, Malla A, Nordentoft M, et al. Early intervention in psychosis: keeping faith with evidence-based health care. Psychol Med. 2010;40(3):399–404.

    Article  PubMed  Google Scholar 

  22. Singh SP, Croudace T, Amin S, Kwiecinski R, Medley I, Jones PB, et al. Three-year outcome of first-episode psychoses in an established community psychiatric service. Br J Psychiatry. 2000;176:210–6.

    Article  PubMed  Google Scholar 

  23. McGorry P. Welcome to early intervention in psychiatry. Early Interv Psychiatry. 2007;1(1):1–2.

    Article  PubMed  Google Scholar 

  24. Saraceno B. New knowledge and new hope to people with emerging mental disorders. Early Interv Psychiatry. 2007;1(1):3–4.

    Article  PubMed  Google Scholar 

  25. Insel TR. The arrival of preemptive psychiatry. Early Interv Psychiatry. 2007;1(1):5–6.

    Article  PubMed  Google Scholar 

  26. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305–26.

    Article  PubMed  Google Scholar 

  27. Group IEPAW. International clinical practice guidelines for early psychosis. Br J Psychiatry Suppl. 2005;48:s120–4.

    Google Scholar 

  28. Jeppesen P, Petersen L, Thorup A, Abel MB, Oehlenschlaeger J, Christensen T, et al. Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial. Br J Psychiatry Suppl. 2005;48:s85–90.

    Article  PubMed  Google Scholar 

  29. Petersen L, Nordentoft M, Jeppesen P, Ohlenschaeger J, Thorup A, Christensen T, et al. Improving 1-year outcome in first-episode psychosis: OPUS trial. Br J Psychiatry Suppl. 2005;48:s98–103.

    Article  PubMed  Google Scholar 

  30. Thorup A, Petersen L, Jeppesen P, Ohlenschlaeger J, Christensen T, Krarup G, et al. Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial. Schizophr Res. 2005;79(1):95–105.

    Article  PubMed  Google Scholar 

  31. Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, et al. Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull. 2006;32(4):758–64.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Crow TJ, MacMillan JF, Johnson AL. Johnstone EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry. 1986;148:120–7.

    Article  PubMed  Google Scholar 

  33. Kane JM, Rifkin A, Quitkin F, Nayak D, Ramos-Lorenzi J. Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatry. 1982;39(1):70–3.

    Article  PubMed  Google Scholar 

  34. Singh SP. Outcome measures in early psychosis; relevance of duration of untreated psychosis. Br J Psychiatry Suppl. 2007;50:s58–63.

    Article  PubMed  Google Scholar 

  35. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994;151(10):1409–16.

    Article  PubMed  Google Scholar 

  36. Norman RM, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry. 2001;179:340–5.

    Article  PubMed  Google Scholar 

  37. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975–83.

    Article  PubMed  Google Scholar 

  38. Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, et al. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res. 2006;83(1):53–63.

    Article  PubMed  Google Scholar 

  39. Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand. 1999;100(2):96–104.

    Article  PubMed  Google Scholar 

  40. Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res. 2005;79(1):85–93.

    Article  PubMed  Google Scholar 

  41. Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 1998;172(33):53–9.

    Article  PubMed  Google Scholar 

  42. Singh SP, Fisher HL. A specialist early intervention for first-episode psychosis. Psychiatr Serv. 2004;55(8):942–3.

    Article  PubMed  Google Scholar 

  43. McGlashan TH. Is active psychosis neurotoxic? Schizophr Bull. 2006;32(4):609–13.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Tirupati NS, Rangaswamy T, Raman P. Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust N Z J Psychiatry. 2004;38(5):339–43.

    Article  PubMed  Google Scholar 

  45. Birchwood M, Connor C, Lester H, Patterson P, Freemantle N, Marshall M, et al. Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services. Br J Psychiatry. 2013;203(1):58–64.

    Article  PubMed  Google Scholar 

  46. Bosanac P, Patton GC, Castle DJ. Early intervention in psychotic disorders: faith before facts? Psychol Med. 2010;40(3):353–8.

    Article  PubMed  Google Scholar 

  47. Norman RM, Malla AK, Verdi MB, Hassall LD, Fazekas C. Understanding delay in treatment for first-episode psychosis. Psychol Med. 2004;34(2):255–66.

    Article  PubMed  Google Scholar 

  48. Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, et al. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology. 2003;28(5):995–1003.

    Article  PubMed  Google Scholar 

  49. Chen EY, Hui CL, Lam MM, Chiu CP, Law CW, Chung DW, et al. Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial. BMJ. 2010;341:c4024.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry. 2007;68(5):654–61.

    Article  PubMed  Google Scholar 

  51. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Int Clin Psychopharmacol. 2008;23(6):325–31.

    Article  PubMed  Google Scholar 

  52. Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, et al. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry. 2005;162(5):947–53.

    Article  PubMed  Google Scholar 

  53. Alvarez-Jiménez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull. 2011;37(3):619–30.

    Article  PubMed  Google Scholar 

  54. Amminger GP, McGorry PD. Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders. Neuropsychopharmacology. 2012;37(1):309–10.

    Article  PubMed  Google Scholar 

  55. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the north American Prodrome longitudinal study. Schizophr Bull. 2009;35(5):894–908.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Nordentoft M, Thorup A, Petersen L, Ohlenschlaeger J, Melau M, Christensen T, et al. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res. 2006;83(1):29–40.

    Article  PubMed  Google Scholar 

  57. Garety PA, Rigg A. Early psychosis in the inner city: a survey to inform service planning. Soc Psychiatry Psychiatr Epidemiol. 2001;36(11):537–44.

    Article  PubMed  Google Scholar 

  58. Jansen JE, Gleeson J, Cotton S. Towards a better understanding of caregiver distress in early psychosis: a systematic review of the psychological factors involved. Clin Psychol Rev. 2015;35:56–66.

    Article  PubMed  Google Scholar 

  59. Stowkowy J, Addington D, Liu L, Hollowell B, Addington J. Predictors of disengagement from treatment in an early psychosis program. Schizophr Res. 2012;136(1–3):7–12.

    Article  PubMed  Google Scholar 

  60. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59(10):921–8.

    Article  PubMed  Google Scholar 

  61. Secher RG, Hjorthøj CR, Austin SF, Thorup A, Jeppesen P, Mors O, et al. Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis. Schizophr Bull. 2015;41(3):617–26.

    Article  PubMed  Google Scholar 

  62. McFarlane WR, Levin B, Travis L, Lucas FL, Lynch S, Verdi M, et al. Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial. Schizophr Bull. 2015;41(1):30–43.

    Article  PubMed  Google Scholar 

  63. Woods SW, Tully EM, Walsh BC, Hawkins KA, Callahan JL, Cohen SJ, et al. Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. Br J Psychiatry Suppl. 2007;51:s96–101.

    Article  PubMed  Google Scholar 

  64. Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry. 2007;68(4):546–57.

    Article  PubMed  Google Scholar 

  65. Woods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D’Souza DC, et al. Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. Eur Neuropsychopharmacol. 2013;23(8):931–40.

    Article  PubMed  Google Scholar 

  66. Kantrowitz JT, Woods SW, Petkova E, Cornblatt B, Corcoran CM, Chen H, et al. D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. Lancet Psychiatry. 2015;2(5):403–12.

    Article  PubMed  Google Scholar 

  67. Woodberry KA, Shapiro DI, Bryant C, Seidman LJ. Progress and future directions in research on the psychosis Prodrome: a review for clinicians. Harv Rev Psychiatry. 2016;24(2):87–103.

    Article  PubMed  PubMed Central  Google Scholar 

  68. McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009;70(9):1206–12.

    Article  PubMed  Google Scholar 

  69. Appelbaum PS. Ethical challenges in the primary prevention of schizophrenia. Schizophr Bull. 2015;41(4):773–5.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Heckers S. Who is at risk for a psychotic disorder? Schizophr Bull. 2009;35(5):847–50.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58(2):158–64.

    Article  PubMed  Google Scholar 

  72. Ross RG, Hunter SK, McCarthy L, Beuler J, Hutchison AK, Wagner BD, et al. Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. Am J Psychiatry. 2013;170(3):290–8.

    Article  PubMed  PubMed Central  Google Scholar 

  73. van der Gaag M, Smit F, Bechdolf A, French P, Linszen DH, Yung AR, et al. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res. 2013;149(1–3):56–62.

    Article  PubMed  Google Scholar 

  74. Consortium SWGotPG. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–7.

    Article  Google Scholar 

  75. Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, et al. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res. 2017;190:90–5.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Amminger GP, Harris MG, Conus P, Lambert M, Elkins KS, Yuen HP, et al. Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatr Scand. 2006;114(5):337–45.

    Article  PubMed  Google Scholar 

  77. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, et al. Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res. 2008;105(1–3):10–7.

    Article  PubMed  Google Scholar 

  78. Yung AR, McGorry PD, Francey SM, Nelson B, Baker K, Phillips LJ, et al. PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust. 2007;187(7 Suppl):S43–6.

    PubMed  Google Scholar 

  79. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ. 2013;346:f185.

    Article  PubMed  PubMed Central  Google Scholar 

  80. National Service Framework: Children, Young People and Maternity Services. England: Department of Health and Social Care; 2004. Available at: https://www.gov.uk/government/publications/national-service-framework-children-young-people-and-maternity-services

  81. Singh SP, Paul M, Ford T, Kramer T, Weaver T. Transitions of care from child and adolescent mental health services to adult mental health services (TRACK study): a study of protocols in greater London. BMC Health Serv Res. 2008;8:135.

    Article  PubMed  PubMed Central  Google Scholar 

  82. New Horizons: Toward a Shared Vision for Mental Health. England: Department of Health (DoH); 2009. Available at: http://www.nwcscnsenate.nhs.uk/files/3714/7497/4308/sharedvis.pdf

  83. No Health Without Mental Health. England: Department of Health; 2011. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/213761/dh_124058.pdf

  84. Mental Health Transitions for Young People. London: Social Care Institute for Excellence; 2011. Available at: https://www.scie.org.uk/.

  85. Davies SC. Our children deserve better. 2013. Available at: https://www.gov.uk/government/news/chief-medical-officer-prevention-pays-our-children-deserve-better

    Google Scholar 

  86. Children and Young People’s Mental Health and Wellbeing Taskforce. 2014. Available at: www.gov.uk/government/groups/children-and-young-peoples-mental-health-and-well-being-taskforce

  87. Lamb N. The government is breaking promises on child mental health. The Guardian. 07/12/2016.

    Google Scholar 

  88. Vyas NS, Birchwood M, Singh SP. Youth services: meeting the mental health needs of adolescents. Irish J Psychol Med. 2015;32(1):13–9.

    Article  Google Scholar 

  89. Rickwood DJT, Parker AG, Tanti CJ, McGorry PD. Australia’s innovation in youth mental health: who are the clients and why are they presenting? Med J Australia. 2014;200(8):454.

    Article  PubMed  Google Scholar 

  90. Office CS. 2011. Available at: www.cso.ie

  91. Coughlan H, Tiedt L, Clarke M, Kelleher I, Tabish J, Molloy C, et al. Prevalence of DSM-IV mental disorders, deliberate self-harm and suicidal ideation in early adolescence: an Irish population-based study. J Adolesc. 2014;37(1):1–9.

    Article  PubMed  Google Scholar 

  92. Kutcher S, Davidson S, Manion I. Child and youth mental health: integrated health care using contemporary competency-based teams. Paediatr Child Health. 2009;14(5):315–8.

    Article  PubMed  PubMed Central  Google Scholar 

  93. McGorry P, Bates T, Birchwood M. Designing youth mental health services for the 21st century: examples from Australia, Ireland and the UK. Br J Psychiatry Suppl. 2013;54:s30–5.

    Article  PubMed  Google Scholar 

  94. Recovery after an initial schizophrenia episode (RAISE): NIMH; 2014. Available at: https://www.nimh.nih.gov/health/topics/schizophrenia/raise/index.shtml

  95. Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry. 2016;173(4):362–72.

    Article  PubMed  Google Scholar 

  96. Large MF, Nielssen O. Duration of untreated psychosis in low and middle income economies: the relationship between GDP and DUP. Br J Psychiatry. 2008;193:272–8.

    Article  PubMed  Google Scholar 

  97. Gureje O, Chisholm D, Kola L, Lasebikan V, Saxena S. Cost-effectiveness of an essential mental health intervention package in Nigeria. World Psychiatry. 2007;6(1):42–8.

    PubMed  PubMed Central  Google Scholar 

  98. Alem A, Jacobsson L, Hanlon C. Community-based mental health care in Africa: mental health workers’ views. World Psychiatry. 2008;7(1):54–7.

    Article  PubMed  PubMed Central  Google Scholar 

  99. McDaid D, Knapp M, Raja S. Barriers in the mind: promoting an economic case for mental health in low- and middle-income countries. World Psychiatry. 2008;7(2):79–86.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Rössler W, Salize HJ, van Os J, Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15(4):399–409.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Warwick, Division of Mental Health and Wellbeing, Coventry, UK

    Swaran Preet Singh

  2. University of Cambridge, Department of Psychiatry, Cambridge, UK

    Benjamin I. Perry

Authors
  1. Swaran Preet Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin I. Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin I. Perry .

Editor information

Editors and Affiliations

  1. Lawson Health Research Institute, Western University Lawson Health Research Institute, London, ON, Canada

    Amresh Shrivastava

  2. Lokmanya Tilak Municipal Medical College, De Sousa Foundation, Mumbai, India

    Avinash De Sousa

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Singh, S.P., Perry, B.I. (2020). Early Intervention in Psychosis. In: Shrivastava, A., De Sousa, A. (eds) Schizophrenia Treatment Outcomes. Springer, Cham. https://doi.org/10.1007/978-3-030-19847-3_22

Download citation

Publish with us

Policies and ethics

Search

Navigation